1,1-dichloroethene decreases expression ISO RGD:10391 6480464 vinylidene chloride results in decreased expression of CPT1B mRNA CTD PMID:26682919 1,2-dichloroethane increases expression ISO RGD:10391 6480464 ethylene dichloride results in increased expression of CPT1B mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:10391 6480464 1, 2-Dimethylhydrazine results in increased expression of CPT1B mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:10391 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPT1B mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:10391 6480464 Estradiol results in decreased expression of CPT1B mRNA CTD PMID:19484750 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CPT1B mRNA CTD PMID:35192832 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:10391 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10391 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:17942748 , PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CPT1B mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10391 6480464 Tetrachlorodibenzodioxin affects the expression of CPT1B mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CPT1B mRNA CTD PMID:22298810 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CPT1B mRNA CTD PMID:21346803 3,3',5-triiodo-L-thyronine increases expression ISO RGD:10391 6480464 Triiodothyronine results in increased expression of CPT1B mRNA CTD PMID:30209975 4-hydroxyphenyl retinamide increases expression ISO RGD:10391 6480464 Fenretinide results in increased expression of CPT1B mRNA CTD PMID:28973697 4-nitroquinoline N-oxide decreases expression ISO RGD:10391 6480464 4-Nitroquinoline-1-oxide results in decreased expression of CPT1B mRNA CTD PMID:22561872 acetamide increases expression EXP 6480464 acetamide results in increased expression of CPT1B mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:619557 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CPT1B mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CPT1B mRNA CTD PMID:32699268 aflatoxin B1 increases methylation ISO RGD:619557 6480464 Aflatoxin B1 results in increased methylation of CPT1B gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CPT1B mRNA CTD PMID:33354967 AICA ribonucleotide multiple interactions EXP 6480464 AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of CPT1B mRNA], AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of CPT1B protein] CTD PMID:19699196 all-trans-retinoic acid increases expression ISO RGD:10391 6480464 Tretinoin results in increased expression of CPT1B mRNA CTD PMID:16840543 all-trans-retinoic acid increases expression ISO RGD:619557 6480464 Tretinoin results in increased expression of CPT1B mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO RGD:619557 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CPT1B mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CPT1B mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CPT1B mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one increases expression ISO RGD:10391 6480464 pyrazolanthrone results in increased expression of CPT1B mRNA CTD PMID:21873422 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:10391 6480464 pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in decreased expression of CPT1B mRNA] CTD PMID:21873422 aristolochic acid A increases expression ISO RGD:619557 6480464 aristolochic acid I results in increased expression of CPT1B mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:10391 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CPT1B protein CTD PMID:32045263 arsenic atom multiple interactions ISO RGD:10391 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CPT1B protein CTD PMID:32045263 arsenous acid decreases expression ISO RGD:619557 6480464 Arsenic Trioxide results in decreased expression of CPT1B mRNA CTD PMID:22521957 aspartame multiple interactions ISO RGD:10391 6480464 [Fats more ... CTD PMID:23783067 benzo[a]pyrene increases expression ISO RGD:10391 6480464 Benzo(a)pyrene results in increased expression of CPT1B mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:619557 6480464 Benzo(a)pyrene affects the methylation of CPT1B 5' UTR, Benzo(a)pyrene affects the methylation of CPT1B promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:10391 6480464 Benzo(a)pyrene results in decreased expression of CPT1B mRNA CTD PMID:22610609 beta-carotene decreases expression ISO RGD:10391 6480464 beta Carotene results in decreased expression of CPT1B mRNA CTD PMID:21569430 bexarotene multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of CPT1B mRNA CTD PMID:17630414 bezafibrate increases expression ISO RGD:10391 6480464 Bezafibrate results in increased expression of CPT1B mRNA CTD PMID:11056218 , PMID:21324916 bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of CPT1B mRNA CTD PMID:11473052 bezafibrate multiple interactions ISO RGD:10391 6480464 PPARA protein affects the reaction [Bezafibrate results in increased expression of CPT1B mRNA] CTD PMID:21324916 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CPT1B mRNA CTD PMID:22672789 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:10391 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CPT1B mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CPT1B mRNA CTD PMID:30816183 , PMID:35192832 bisphenol A multiple interactions ISO RGD:10391 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A decreases expression ISO RGD:10391 6480464 bisphenol A results in decreased expression of CPT1B mRNA CTD PMID:24959901 , PMID:27502578 carbon nanotube increases expression ISO RGD:10391 6480464 Nanotubes more ... CTD PMID:25620056 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of CPT1B mRNA CTD PMID:18500788 choline multiple interactions ISO RGD:10391 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CPT1B mRNA CTD PMID:20938992 ciprofibrate increases expression EXP 6480464 ciprofibrate results in increased expression of CPT1B mRNA CTD PMID:27225895 ciprofibrate increases expression ISO RGD:10391 6480464 ciprofibrate results in increased expression of CPT1B mRNA CTD PMID:27225895 clofibrate increases expression ISO RGD:10391 6480464 Clofibrate results in increased expression of CPT1B mRNA CTD PMID:23811191 , PMID:25270620 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CPT1B mRNA CTD PMID:12011481 more ... cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of CPT1B mRNA CTD PMID:11549245 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of CPT1B mRNA CTD PMID:17418555 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of CPT1B mRNA CTD PMID:17418555 Di-n-hexyl phthalate decreases expression ISO RGD:619557 6480464 di-n-hexyl phthalate results in decreased expression of CPT1B mRNA CTD PMID:33043605 diarsenic trioxide decreases expression ISO RGD:619557 6480464 Arsenic Trioxide results in decreased expression of CPT1B mRNA CTD PMID:22521957 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CPT1B mRNA CTD PMID:21266533 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of CPT1B mRNA CTD PMID:18636392 dichlorine increases expression EXP 6480464 Chlorine results in increased expression of CPT1B mRNA CTD PMID:18636392 dioxygen decreases expression ISO RGD:10391 6480464 Oxygen deficiency results in decreased expression of CPT1B mRNA CTD PMID:21113404 dioxygen multiple interactions ISO RGD:10391 6480464 rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of CPT1B mRNA] CTD PMID:21113404 dipentyl phthalate increases expression EXP 6480464 di-n-pentyl phthalate results in increased expression of CPT1B mRNA CTD PMID:33983380 dorsomorphin multiple interactions EXP 6480464 dorsomorphin promotes the reaction [Phenylephrine results in decreased expression of CPT1B mRNA], dorsomorphin promotes the reaction [Phenylephrine results in decreased expression of CPT1B protein] CTD PMID:19699196 dorsomorphin decreases expression EXP 6480464 dorsomorphin results in decreased expression of CPT1B mRNA, dorsomorphin results in decreased expression of CPT1B protein CTD PMID:19699196 doxorubicin decreases expression ISO RGD:10391 6480464 Doxorubicin results in decreased expression of CPT1B mRNA CTD PMID:26873546 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CPT1B mRNA CTD PMID:29391264 ethanol decreases expression ISO RGD:10391 6480464 Ethanol results in decreased expression of CPT1B mRNA CTD PMID:34995708 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of CPT1B mRNA CTD PMID:16595124 more ... fenofibrate multiple interactions EXP 6480464 Fenofibrate inhibits the reaction [Pyrazinamide results in decreased expression of CPT1B mRNA] CTD PMID:27071702 fenofibrate affects expression EXP 6480464 Fenofibrate affects the expression of CPT1B mRNA CTD PMID:20801182 finasteride increases expression EXP 6480464 Finasteride results in increased expression of CPT1B mRNA CTD PMID:24136188 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CPT1B mRNA CTD PMID:18035473 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CPT1B mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:10391 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CPT1B mRNA CTD PMID:20938992 folic acid increases expression ISO RGD:10391 6480464 Folic Acid results in increased expression of CPT1B mRNA CTD PMID:25629700 gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of CPT1B mRNA CTD PMID:12011481 , PMID:32741897 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CPT1B mRNA CTD PMID:33387578 graphite increases expression ISO RGD:10391 6480464 Graphite results in increased expression of CPT1B mRNA CTD PMID:27440207 GW 501516 increases expression EXP 6480464 GW 501516 results in increased expression of CPT1B mRNA CTD PMID:18701451 GW 501516 multiple interactions EXP 6480464 RELA protein inhibits the reaction [GW 501516 results in increased expression of CPT1B mRNA] CTD PMID:18701451 GW 6471 multiple interactions ISO RGD:10391 6480464 GW 6471 inhibits the reaction [GW 7647 results in increased expression of CPT1B mRNA] CTD PMID:21324916 GW 6471 decreases expression ISO RGD:10391 6480464 GW 6471 results in decreased expression of CPT1B mRNA CTD PMID:21324916 GW 7647 multiple interactions ISO RGD:10391 6480464 GW 6471 inhibits the reaction [GW 7647 results in increased expression of CPT1B mRNA] more ... CTD PMID:21324916 GW 7647 increases expression ISO RGD:10391 6480464 GW 7647 results in increased expression of CPT1B mRNA CTD PMID:21324916 hydroxytyrosol decreases expression ISO RGD:10391 6480464 3, 4-dihydroxyphenylethanol results in decreased expression of CPT1B mRNA CTD PMID:21569430 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPT1B mRNA CTD PMID:22129741 isoprenaline multiple interactions EXP 6480464 Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of CPT1B mRNA], TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of CPT1B mRNA]] CTD PMID:25045214 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of CPT1B mRNA CTD PMID:25045214 L-methionine multiple interactions ISO RGD:10391 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CPT1B mRNA CTD PMID:20938992 lenvatinib decreases expression EXP 6480464 lenvatinib results in decreased expression of CPT1B mRNA, lenvatinib results in decreased expression of CPT1B protein CTD PMID:35788046 lenvatinib decreases expression ISO RGD:10391 6480464 lenvatinib results in decreased expression of CPT1B protein CTD PMID:35788046 lipopolysaccharide decreases expression ISO RGD:10391 6480464 Lipopolysaccharides results in decreased expression of CPT1B mRNA CTD PMID:18940942 , PMID:21873422 lipopolysaccharide multiple interactions ISO RGD:10391 6480464 pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in decreased expression of CPT1B mRNA] CTD PMID:21873422 meldonium decreases expression ISO RGD:10391 6480464 3-(2 more ... CTD PMID:32389661 methotrexate decreases expression ISO RGD:10391 6480464 Methotrexate results in decreased expression of CPT1B mRNA CTD PMID:18502557 metoprolol multiple interactions EXP 6480464 Metoprolol inhibits the reaction [[[PPARGC1A protein results in increased expression of MEF2A mRNA] co-treated with [PPARGC1A protein results in increased expression of PPARA mRNA]] results in increased expression of CPT1B protein] more ... CTD PMID:19233164 metoprolol decreases expression EXP 6480464 Metoprolol results in decreased expression of CPT1B protein CTD PMID:19233164 monosodium L-glutamate increases expression ISO RGD:10391 6480464 Sodium Glutamate results in increased expression of CPT1B mRNA CTD PMID:19724016 monosodium L-glutamate multiple interactions ISO RGD:10391 6480464 [Fats more ... CTD PMID:19001666 more ... Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CPT1B mRNA CTD PMID:21515302 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPT1B mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPT1B mRNA CTD PMID:22129741 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of CPT1B mRNA CTD PMID:33484710 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of CPT1B mRNA CTD PMID:23665939 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of CPT1B mRNA CTD PMID:30316929 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of CPT1B mRNA CTD PMID:18636392 ozone multiple interactions ISO RGD:619557 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CPT1B mRNA more ... CTD PMID:32699268 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CPT1B mRNA CTD PMID:33387578 perflubutane increases expression ISO RGD:10391 6480464 perfluorobutane results in increased expression of CPT1B mRNA CTD PMID:23567314 perfluorobutyric acid increases expression ISO RGD:10391 6480464 perfluorobutyric acid results in increased expression of CPT1B mRNA CTD PMID:23567314 perfluorodecanoic acid increases expression ISO RGD:10391 6480464 perfluorodecanoic acid results in increased expression of CPT1B mRNA CTD PMID:23567314 perfluoroheptanoic acid affects expression ISO RGD:10391 6480464 perfluoro-n-heptanoic acid affects the expression of CPT1B mRNA CTD PMID:23567314 perfluorohexanesulfonic acid increases expression ISO RGD:10391 6480464 perfluorohexanesulfonic acid results in increased expression of CPT1B mRNA CTD PMID:21705711 perfluorohexanesulfonic acid affects expression ISO RGD:10391 6480464 perfluorohexanesulfonic acid affects the expression of CPT1B mRNA CTD PMID:23567314 perfluorohexanoic acid increases expression ISO RGD:10391 6480464 perfluorohexanoic acid results in increased expression of CPT1B mRNA CTD PMID:23567314 perfluorononanoic acid affects expression ISO RGD:10391 6480464 perfluoro-n-nonanoic acid affects the expression of CPT1B mRNA CTD PMID:23567314 perfluorononanoic acid increases expression ISO RGD:619557 6480464 perfluoro-n-nonanoic acid results in increased expression of CPT1B mRNA CTD PMID:35337807 perfluorononanoic acid multiple interactions ISO RGD:10391 6480464 [Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in increased expression of CPT1B mRNA CTD PMID:33483757 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CPT1B mRNA CTD PMID:18692542 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10391 6480464 [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of CPT1B mRNA CTD PMID:32979393 perfluorooctane-1-sulfonic acid increases expression ISO RGD:10391 6480464 perfluorooctane sulfonic acid results in increased expression of CPT1B mRNA CTD PMID:21705711 more ... perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CPT1B mRNA CTD PMID:16221955 more ... perfluorooctanoic acid increases expression ISO RGD:619557 6480464 perfluorooctanoic acid results in increased expression of CPT1B mRNA CTD PMID:23978341 perfluorooctanoic acid multiple interactions ISO RGD:10391 6480464 Dietary Fats, Unsaturated promotes the reaction [perfluorooctanoic acid results in increased expression of CPT1B mRNA] CTD PMID:23626681 perfluorooctanoic acid increases expression ISO RGD:10391 6480464 perfluorooctanoic acid results in increased expression of CPT1B mRNA CTD PMID:17681415 more ... permethrin decreases expression ISO RGD:10391 6480464 Permethrin results in decreased expression of CPT1B mRNA CTD PMID:24911977 phenobarbital affects expression ISO RGD:10391 6480464 Phenobarbital affects the expression of CPT1B mRNA CTD PMID:19136022 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CPT1B mRNA CTD PMID:19162173 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CPT1B mRNA CTD PMID:12011481 phenylephrine multiple interactions EXP 6480464 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in decreased expression of CPT1B mRNA] more ... CTD PMID:15721863 , PMID:19699196 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of CPT1B mRNA, Phenylephrine results in decreased expression of CPT1B protein CTD PMID:15721863 , PMID:19699196 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of CPT1B mRNA CTD PMID:11879187 picrotoxin increases expression EXP 6480464 Picrotoxin results in increased expression of CPT1B mRNA CTD PMID:15170462 pioglitazone increases expression ISO RGD:10391 6480464 pioglitazone results in increased expression of CPT1B mRNA CTD PMID:20723549 pirinixic acid multiple interactions ISO RGD:10391 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CPT1B mRNA more ... CTD PMID:17275789 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CPT1B mRNA CTD PMID:12011481 more ... pirinixic acid increases expression ISO RGD:10391 6480464 pirinixic acid results in increased expression of CPT1B mRNA CTD PMID:17950772 more ... pirinixic acid multiple interactions EXP 6480464 RELA protein inhibits the reaction [pirinixic acid results in increased expression of CPT1B mRNA] CTD PMID:18701451 pirinixic acid affects expression ISO RGD:10391 6480464 pirinixic acid affects the expression of CPT1B mRNA CTD PMID:19136022 pravastatin decreases expression ISO RGD:10391 6480464 Pravastatin results in decreased expression of CPT1B mRNA CTD PMID:27225895 pravastatin affects expression EXP 6480464 Pravastatin affects the expression of CPT1B mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of CPT1B mRNA CTD PMID:19162173 progesterone increases expression EXP 6480464 Progesterone results in increased expression of CPT1B mRNA CTD PMID:20726854 pyrazinecarboxamide decreases expression EXP 6480464 Pyrazinamide results in decreased expression of CPT1B mRNA CTD PMID:22431067 , PMID:27071702 pyrazinecarboxamide multiple interactions EXP 6480464 Fenofibrate inhibits the reaction [Pyrazinamide results in decreased expression of CPT1B mRNA] CTD PMID:27071702 quercetin increases expression ISO RGD:619557 6480464 Quercetin results in increased expression of CPT1B mRNA CTD PMID:21632981 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CPT1B mRNA CTD PMID:28374803 sirolimus multiple interactions EXP 6480464 Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of CPT1B mRNA], TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of CPT1B mRNA]] CTD PMID:25045214 sodium arsenite multiple interactions ISO RGD:10391 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CPT1B protein CTD PMID:32045263 sodium fluoride increases expression ISO RGD:10391 6480464 Sodium Fluoride results in increased expression of CPT1B protein CTD PMID:28918527 tamoxifen multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of CPT1B mRNA CTD PMID:17630414 temozolomide increases expression ISO RGD:619557 6480464 Temozolomide results in increased expression of CPT1B mRNA CTD PMID:31758290 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CPT1B mRNA CTD PMID:21515302 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CPT1B mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide decreases expression ISO RGD:10391 6480464 titanium dioxide results in decreased expression of CPT1B mRNA CTD PMID:23557971 trichloroethene increases expression ISO RGD:10391 6480464 Trichloroethylene results in increased expression of CPT1B mRNA CTD PMID:25549359 trichostatin A decreases expression ISO RGD:619557 6480464 trichostatin A results in decreased expression of CPT1B mRNA CTD PMID:26272509 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of CPT1B mRNA CTD PMID:30589522 Triptolide decreases expression ISO RGD:10391 6480464 triptolide results in decreased expression of CPT1B mRNA CTD PMID:31241159 troglitazone increases expression ISO RGD:10391 6480464 troglitazone results in increased expression of CPT1B mRNA CTD PMID:12920214 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CPT1B mRNA CTD PMID:21515302 troglitazone increases expression ISO RGD:619557 6480464 troglitazone results in increased expression of CPT1B mRNA CTD PMID:12759900 valproic acid decreases expression ISO RGD:619557 6480464 Valproic Acid results in decreased expression of CPT1B mRNA CTD PMID:26272509 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CPT1B mRNA CTD PMID:29427782 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of CPT1B mRNA CTD PMID:27225895 zaragozic acid A affects expression ISO RGD:10391 6480464 squalestatin 1 affects the expression of CPT1B mRNA CTD PMID:27225895
